Recommendations for prevention and treatment of Esophago-Gastro-Entero-Colopathies induced by non-steroid anti-inflammatory drugs (NSAIDs) - 2025

Since the publication of the Guidelines for the Prevention and Treatment of Esophago-Gastro-Entero-Colopathies Induced by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in 2018, seven years have passed. New information has emerged, leading to a deeper understanding and new approaches. However, the issue of appropriate polypharmacotherapy for comorbid patients remains highly relevant. We hope that our updated version of the guidelines for the prevention and management of NSAID-related adverse effects will assist physicians in addressing these critical challenges more effectively.

Authors

Institutions

Publication Details

Journal
Experimental and Clinical Gastroenterology
Published
2024-12-30
DOI
https://doi.org/10.31146/1682-8658-ecg-232-12-146-166
Citations
2
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
1.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recommendations for prevention and treatment of Esophago-Gastro-Entero-Colopathies induced by non-steroid anti-inflammatory drugs (NSAIDs) - 2025

Tkachenko Ei, Е. В. Онучина, С. В. Туркина, O. Yu. Pozdnyakova et al.
2 citations
Experimental and Clinical Gastroenterology
Eosinophilic Esophagitis
1.15
article

Recommendations for prevention and treatment of Esophago-Gastro-Entero-Colopathies induced by non-steroid anti-inflammatory drugs (NSAIDs) - 2025

Tkachenko Ei, Е. В. Онучина, С. В. Туркина, O. Yu. Pozdnyakova, Г. В. Белова, Е. И. Кашкина, О. В. Хлынова, Kokorin V.A. Kokorin, А. С. Сарсенбаева, E. S. Vyuchnova, É. P. Yakovenko, О. В. Мирончев, И. Г. Пахомова, Л. Б. Лазебник, И. В. Козлова, С. А. Алексеенко, Andrey Petrovich Rachin, С. И. Ситкин, A.A. Shchegolev, O. V. Yakob
article en
2 citations

Abstract

Since the publication of the Guidelines for the Prevention and Treatment of Esophago-Gastro-Entero-Colopathies Induced by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in 2018, seven years have passed. New information has emerged, leading to a deeper understanding and new approaches. However, the issue of appropriate polypharmacotherapy for comorbid patients remains highly relevant. We hope that our updated version of the guidelines for the prevention and management of NSAID-related adverse effects will assist physicians in addressing these critical challenges more effectively.

Experimental and Clinical Gastroenterology(12)
Volgograd State Medical University (RU), S. M. Kirov Military Medical Academy (RU), Federal Almazov North-West Medical Research Centre (RU), Pirogov Russian National Research Medical University (RU), Perm State Medical Academy (RU), Ural State Medical University (RU), National Communication Association (US), Russian Medical Academy of Continuous Professional Education (RU), Ministry of Health of the Russian Federation (RU), Saratov State Medical University (RU), Orenburg State Medical Academy (RU), Far Eastern State Medical University (RU), North-Western State Medical University named after I.I. Mechnikov (RU), Federal Medical-Biological Agency (RU)
Openalex Percentile: Top 18%
Eosinophilic Esophagitis
1.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.